ACET Return on Tangible Equity | Adicet Bio, Inc.

Adicet Bio, Inc. (ACET) Return on Tangible Equity

2026-06-30: Return Tang Equity -82.38%.
2026-03-31: Return Tang Equity -77.70%.
2025-12-31: Return Tang Equity -73.36%.
2025-09-30: Return Tang Equity -105.38%.

Complete source-backed return tang equity history.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-82.38%
2026-03-31	-77.70%
2025-12-31	-73.36%
2025-09-30	-105.38%
2025-06-30	-88.95%
2025-03-31	-72.67%
2024-12-31	-62.76%
2024-09-30	-55.73%
2024-06-30	-58.39%
2024-03-31	-54.02%
2023-12-31	-83.83%
2023-09-30	-73.48%
2023-06-30	-52.44%
2023-03-31	-42.67%
2022-12-31	-25.58%
2022-09-30	-18.69%
2022-06-30	-17.44%
2022-03-31	-12.37%
2021-12-31	-21.86%
2021-09-30	-27.88%
2021-06-30	-26.77%
2021-03-31	-24.73%
2020-12-31	-40.87%
2020-09-30	-35.66%
2020-06-30	47.35%
2020-03-31	44.16%
2019-12-31	46.61%
2019-09-30	-1.84%
2019-06-30	-18.54%
2019-03-31	9.57%
2018-12-31	27.74%
2018-09-30	-50.22%
2018-06-30	-42.52%
2018-03-31	-30.89%
2017-12-31	125.35%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-73.36%
2024-12-31	-62.76%
2023-12-31	-83.83%
2022-12-31	-25.58%
2021-12-31	-21.86%
2020-12-31	-40.87%
2019-12-31	46.61%
2018-12-31	27.74%
2017-12-31	125.35%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Valion Bio, Inc. (VBIO)	United States	$0.077B
Lifevantage Corp (LFVN)	United States	$0.078B	15.40
MAIA Biotechnology, Inc. (MAIA)	United States	$0.077B	-2.30
iBio, Inc. (IBIO)	United States	$0.077B	-2.94
Verrica Pharmaceuticals Inc. (VRCA)	United States	$0.076B	-3.39
OS Therapies Inc (OSTX)	United States	$0.076B	-2.17
Gain Therapeutics, Inc. (GANX)	United States	$0.080B	-4.40
Aldeyra Therapeutics, Inc. (ALDX)	United States	$0.074B	-5.57
Cingulate Inc. (CING)	United States	$0.073B	-2.64
Spero Therapeutics, Inc. (SPRO)	United States	$0.073B	17.41